JAK inhibitor group:None
Sponsors
The First Affiliated Hospital of Wenzhou Medical University
Conditions
Ankylosing SpondylitisAxial Spondyloarthritis
Unknown Phase
Omics reveal heterogeneity in the efficacy of targeted drug therapy in axial spondyloarthritis and construct predictive models
Active, not recruitingChiCTR2500105344
Start: 2025-07-15Updated: 2025-07-07
A Multicenter, Prospective, Propensity Score-Matched Study Comparing the Efficacy and Safety of Infliximab versus JAK Inhibitors in Ankylosing Spondylitis Patients with Inadequate Response to IL-17 Inhibitors
Active, not recruitingChiCTR2600126280
Start: 2026-06-06Updated: 2026-06-08